DPP4 and type 2 diabetes mellitus: This cohort study investigated whether SGLT2i use, compared to dipeptidyl peptidase-4 inhibitors (DPP-4i), is associated with a lower incidence of IDA in T2DM.<h4>Materials and methods</h4>We analysed data from the IQVIATM Disease Analyzer, a German electronic medical records database (ICD-10) from office-based practices.